Logo image of LIZI

LIZHI INC (LIZI) Stock Fundamental Analysis

NASDAQ:LIZI - Nasdaq - US53933L2034 - ADR - Currency: USD

2.8  +0.06 (+2.19%)

After market: 2.89 +0.09 (+3.21%)

Fundamental Rating

5

Taking everything into account, LIZI scores 5 out of 10 in our fundamental rating. LIZI was compared to 72 industry peers in the Entertainment industry. Both the profitability and the financial health of LIZI get a neutral evaluation. Nothing too spectacular is happening here. LIZI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make LIZI suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

LIZI had positive earnings in the past year.
LIZI had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: LIZI reported negative operating cash flow in multiple years.
LIZI Yearly Net Income VS EBIT VS OCF VS FCFLIZI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 0 -200M -400M -600M -800M -1B

1.2 Ratios

With an excellent Return On Assets value of 14.87%, LIZI belongs to the best of the industry, outperforming 97.26% of the companies in the same industry.
The Return On Equity of LIZI (23.66%) is better than 93.15% of its industry peers.
With an excellent Return On Invested Capital value of 14.23%, LIZI belongs to the best of the industry, outperforming 93.15% of the companies in the same industry.
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROIC 14.23%
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIZI Yearly ROA, ROE, ROICLIZI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 0 500 -500 1K 1.5K 2K

1.3 Margins

With an excellent Profit Margin value of 4.79%, LIZI belongs to the best of the industry, outperforming 80.82% of the companies in the same industry.
LIZI has a better Operating Margin (3.72%) than 65.75% of its industry peers.
The Gross Margin of LIZI (31.28%) is comparable to the rest of the industry.
LIZI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
LIZI Yearly Profit, Operating, Gross MarginsLIZI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 0 20 -20 -40 -60 -80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LIZI is creating value.
Compared to 1 year ago, LIZI has more shares outstanding
Compared to 1 year ago, LIZI has an improved debt to assets ratio.
LIZI Yearly Shares OutstandingLIZI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
LIZI Yearly Total Debt VS Total AssetsLIZI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

LIZI has an Altman-Z score of 0.35. This is a bad value and indicates that LIZI is not financially healthy and even has some risk of bankruptcy.
LIZI has a Altman-Z score (0.35) which is in line with its industry peers.
LIZI has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
LIZI has a Debt to Equity ratio of 0.01. This is in the better half of the industry: LIZI outperforms 78.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.35
ROIC/WACC1.94
WACC7.35%
LIZI Yearly LT Debt VS Equity VS FCFLIZI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 0 100M -100M 200M 300M

2.3 Liquidity

LIZI has a Current Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.58, LIZI belongs to the best of the industry, outperforming 80.82% of the companies in the same industry.
LIZI has a Quick Ratio of 2.58. This indicates that LIZI is financially healthy and has no problem in meeting its short term obligations.
LIZI has a Quick ratio of 2.58. This is amongst the best in the industry. LIZI outperforms 80.82% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.58
LIZI Yearly Current Assets VS Current LiabilitesLIZI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 200M 400M 600M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1683.33% over the past year.
Looking at the last year, LIZI shows a quite strong growth in Revenue. The Revenue has grown by 13.31% in the last year.
The Revenue has been growing by 36.96% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%

3.2 Future

The Earnings Per Share is expected to decrease by -48.05% on average over the next years. This is quite bad
Based on estimates for the next years, LIZI will show a very strong growth in Revenue. The Revenue will grow by 114.98% on average per year.
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LIZI Yearly Revenue VS EstimatesLIZI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
LIZI Yearly EPS VS EstimatesLIZI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.92, the valuation of LIZI can be described as very cheap.
Based on the Price/Earnings ratio, LIZI is valued cheaper than 100.00% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, LIZI is valued rather cheaply.
A Price/Forward Earnings ratio of 10.34 indicates a reasonable valuation of LIZI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LIZI indicates a rather cheap valuation: LIZI is cheaper than 89.04% of the companies listed in the same industry.
LIZI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.08.
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
LIZI Price Earnings VS Forward Price EarningsLIZI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.38
LIZI Per share dataLIZI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

A cheap valuation may be justified as LIZI's earnings are expected to decrease with -48.05% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%

0

5. Dividend

5.1 Amount

No dividends for LIZI!.
Industry RankSector Rank
Dividend Yield N/A

LIZHI INC

NASDAQ:LIZI (1/24/2024, 8:00:03 PM)

After market: 2.89 +0.09 (+3.21%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-14 2023-11-14/bmo
Earnings (Next)03-14 2024-03-14/amc
Inst Owners1.35%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.82M
Analysts85.71
Price Target1.43 (-48.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 0.92
Fwd PE 10.34
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.22
P/tB 0.22
EV/EBITDA -5.38
EPS(TTM)3.04
EY108.57%
EPS(NY)0.27
Fwd EY9.67%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS62.58
BVpS12.66
TBVpS12.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 14.87%
ROE 23.66%
ROCE 18.29%
ROIC 14.23%
ROICexc N/A
ROICexgc N/A
OM 3.72%
PM (TTM) 4.79%
GM 31.28%
FCFM N/A
ROA(3y)-19.87%
ROA(5y)-183.51%
ROE(3y)-55.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.69%
GM growth 5Y3.91%
F-ScoreN/A
Asset Turnover3.11
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.07
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.58
Altman-Z 0.35
F-ScoreN/A
WACC7.35%
ROIC/WACC1.94
Cap/Depr(3y)93.44%
Cap/Depr(5y)138.6%
Cap/Sales(3y)1.02%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1683.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next Y-96.37%
EPS Next 2Y-68.59%
EPS Next 3Y-48.05%
EPS Next 5YN/A
Revenue 1Y (TTM)13.31%
Revenue growth 3Y22.78%
Revenue growth 5Y36.96%
Sales Q2Q%14.97%
Revenue Next Year747.7%
Revenue Next 2Y209.26%
Revenue Next 3Y114.98%
Revenue Next 5YN/A
EBIT growth 1Y1575%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-82.2%
EBIT Next 3Y15.08%
EBIT Next 5YN/A
FCF growth 1Y303.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y437.38%
OCF growth 3YN/A
OCF growth 5YN/A